Trump admired Modi for selling Anti-malaria drug and denied investing in Hydroxychloroquine
US President Donald Trump has rejected claim for having any investments in the anti-malaria drug hydroxychloroquine. It is noteworthy that he has consistently presented the drug as reliable treatment for coronavirus patients. He was asked when he was leaving his latest coronavirus briefing
Recent Comments